187 related articles for article (PubMed ID: 33131917)
1. Gastroprotective Therapy.
Tolbert MK
Vet Clin North Am Small Anim Pract; 2021 Jan; 51(1):33-41. PubMed ID: 33131917
[TBL] [Abstract][Full Text] [Related]
2. [Indications for anti-ulcer drugs in adults].
Chassany O
Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
[No Abstract] [Full Text] [Related]
3. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of heartburn. An update on therapies.
Wright W
Adv Nurse Pract; 2010 Apr; 18(4):24-9; quiz 30. PubMed ID: 20486300
[No Abstract] [Full Text] [Related]
5. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
Kawai T; Yagi K; Moriyasu F
Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
[TBL] [Abstract][Full Text] [Related]
6. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
[TBL] [Abstract][Full Text] [Related]
8. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists.
Daure E; Ross L; Webster CR
J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679
[TBL] [Abstract][Full Text] [Related]
9. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study.
Carvajal A; Arias LH; Vega E; Sánchez JA; RodrÃguez IM; Ortega PG; del Pozo JG
Eur J Clin Pharmacol; 2004 Aug; 60(6):439-44. PubMed ID: 15221157
[TBL] [Abstract][Full Text] [Related]
10. ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.
Marks SL; Kook PH; Papich MG; Tolbert MK; Willard MD
J Vet Intern Med; 2018 Nov; 32(6):1823-1840. PubMed ID: 30378711
[TBL] [Abstract][Full Text] [Related]
11. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Evseev MA; Ivakhov GB; Golovin RA
Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
13. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
[TBL] [Abstract][Full Text] [Related]
14. Drug Utilization Study of Gastroprotective Agents in Medicine and Surgery Wards of a Tertiary Care Teaching Hospital.
Koyani H; Vora N; Kalathia M; Patel N; Shah S
Cureus; 2023 Jan; 15(1):e33739. PubMed ID: 36793848
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
Yang Z; Wu Q; Liu Z; Wu K; Fan D
Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
[TBL] [Abstract][Full Text] [Related]
16. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
Harasawa S
Nihon Rinsho; 2000 Sep; 58(9):1847-52. PubMed ID: 11004814
[TBL] [Abstract][Full Text] [Related]
17. Stress-related mucosal disease: risk factors and prophylactic therapy.
Spirt MJ
Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
[TBL] [Abstract][Full Text] [Related]
18. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Scheen AJ
Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
20. Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease.
Ivashkin VT; Maev IV; Trukhmanov AS; Rumyantseva DE
Ter Arkh; 2018 Aug; 90(8):4-12. PubMed ID: 30701934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
